打司美格鲁肽的中年男人，困在「减肥羞耻」里

Core Viewpoint - The article discusses the increasing trend of middle-aged men using the drug Semaglutide for weight loss, highlighting the societal pressures and personal motivations behind this phenomenon [5][16][38]. Group 1: Usage of Semaglutide - Semaglutide, a GLP-1 receptor agonist, allows users to maintain a sense of fullness, leading to rapid weight loss, as exemplified by an individual who lost 20 pounds in 15 days [5][13]. - The drug is primarily prescribed to individuals with a BMI over 30 or those with obesity-related comorbidities, but many men use it without medical guidance, leading to potential misuse [9][10]. - The price of Semaglutide has decreased significantly over the years, making it more accessible, with the cost dropping from 1120 RMB to around 421.34 RMB for a 2mg dose [36]. Group 2: Societal and Psychological Factors - There is a societal stigma around men discussing weight loss, leading to a culture where they prefer terms like "body management" over "dieting" [6][17]. - Middle-aged men often experience a sense of shame and anxiety regarding their weight, which is compounded by societal expectations of appearance and health [11][22]. - The desire for a healthier appearance is often driven by professional and social pressures, as men in mid-level positions feel the need to present themselves well in business contexts [18][20]. Group 3: Health Implications and Challenges - Many men face health issues related to obesity, such as high blood pressure and cholesterol, which often serve as a wake-up call for weight management [19][18]. - The article notes that men generally have lower self-discipline in weight management compared to women, often requiring external motivation to maintain a healthy lifestyle [33]. - The long-term effects of using Semaglutide remain uncertain, with medical professionals advising caution and regular health checks for those using the drug [41]. Group 4: Market Trends and Future Outlook - The market for weight loss drugs is expanding, with numerous companies developing alternatives to Semaglutide, indicating a growing demand for effective weight management solutions [38]. - The introduction of oral versions of Semaglutide is expected to further increase accessibility and appeal to a broader audience [37]. - As societal norms shift towards valuing a fit appearance, the relationship between weight management and social status is becoming more pronounced, potentially linking obesity to economic and social factors [21][26].